Peer Review History
| Original SubmissionOctober 27, 2020 |
|---|
|
PONE-D-20-33796 Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: A nation-wide population-based study PLOS ONE Dear Dr.Liedberg, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Comments and questions; 1- Please comment and add information about postoperative ‘’ileus’’ incidence and correlation with MIH. 2- There is some punctuation and printing mistakes in the text as in page 3 line 99 ‘’preforming’’!. Please check and consider for editing and proofreading. 3- Please add comment about follow-up time that is 2.3 years. Is it sufficient or not? 4- I would like to know that did ERAS protocol use in study group If yes, what was ERAS protocol a relation with MIH? 5- In discussion section, ‘’limitation’’ part must be in last paragraph of this section. 6-In discussion section, you have to discuss your results with literature; for example in seconda paragraph; there is no reference! 7- In this study authors reported that robotic surgery increased risk of MIH by two fold. Please ad a comment about intrabdominal pressure and its effects on radical cystectomy and also MIH. 8- In table 1a, please correct in order for ‘’Previous inguinal hernia repair; No , Yes ...results. 9- The resolutions of Figure 1a and 1b are insufficient; I could not read the details of these figures. Please submit your revised manuscript by 21 January 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Emre Bozkurt Academic Editor PLOS ONE Additional Editor Comments: Dear author, Thank you for your well-designed manuscript. It needs some corrections before acceptance for publishing. 1- Please comment and add information about postoperative ‘’ileus’’ incidence and correlation with MIH. 2- There is some punctuation and printing mistakes in the text as in page 3 line 99 ‘’preforming’’!. Please check and consider for editing and proofreading. 3- Please add comment about follow-up time that is 2.3 years. Is it sufficient or not? 4- I would like to know that did ERAS protocol use in study group If yes, what was ERAS protocol a relation with MIH? 5- In discussion section, ‘’limitation’’ part must be in last paragraph of this section. 6-In discussion section, you have to discuss your results with literature; for example in seconda paragraph; there is no reference! 7- In this study authors reported that robotic surgery increased risk of MIH by two fold. Please ad a comment about intrabdominal pressure and its effects on radical cystectomy and also MIH. 8- In table 1a, please correct in order for ‘’Previous inguinal hernia repair; No , Yes ...results. 9- The resolutions of Figure 1a and 1b are insufficient; I could not read the details of these figures. Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables should be uploaded as separate "supporting information" files. 3. In your ethics statement in the Methods section and in the online submission form, please provide additional information about the data used in your retrospective study. Specifically, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Line 139: "-" sign is missing in the URL, please correct the URL as https://www.R-project.org/ Line 227-247: Please move the paragraph about limitations of the letter to the final part of discussion section Reviewer #2: Dear authors, This is a valuable orginal article about incidence of midline incisional hernia in surgery after radical cystectomy and urinary diversion for bladder cancer from Sweden. Thank you for your great effort but there are some concerns about the study. Comments to authors; 1- Please comment and add information about postoperative ‘’ileus’’ incidence and correlation with MIH. 2- There is some punctuation and printing mistakes in the text as in page 3 line 99 ‘’preforming’’!. Please check and consider for editing and proofreading. 3- Please add comment about follow-up time that is 2.3 years. Is it sufficient or not? 4- I would like to know that did ERAS protocol use in study group If yes, what was ERAS protocol a relation with MIH? 5- In discussion section, ‘’limitation’’ part must be in last paragraph of this section. 6-In discussion section, you have to discuss your results with literature; for example in seconda paragraph; there is no reference! 7- In this study authors reported that robotic surgery increased risk of MIH by two fold. Please ad a comment about intrabdominal pressure and its effects on radical cystectomy and also MIH. 8- In table 1a, please correct in order for ‘’Previous inguinal hernia repair; No , Yes ...results. 9- The resolutions of Figure 1a and 1b are insufficient; I could not read the details of these figures. Sincerely yours ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: A nation-wide population-based study PONE-D-20-33796R1 Dear Dr. Liedberg, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Emre Bozkurt Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-20-33796R1 Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: A nation-wide population-based study Dear Dr. Liedberg: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Emre Bozkurt Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .